Search
for
Sort by
Research 571–600 of 1000+
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Tofacitinib therapy for children with severe alopecia areata
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Current and future pharmacotherapy for alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Mechanism of PPARα agonist in alopecia areata
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Healing hair naturally: A case study of alopecia areata treated with individualized homeopathy